However, since defective GLUT1 causes hypoglycorrhachia, seizures, and developmental delay [117,118,119], it remains unclear whether BBB dysregulation is a central mechanism initiating disease progression in GLUT1-related AD pathogenesis. The gene discussed is SLC2A1; the disease is Global developmental delay.